IMMUNE THROMBOCYTOPENIA (ITP)
Clinical trials for IMMUNE THROMBOCYTOPENIA (ITP) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to boost platelets in stubborn blood disorder
Disease control Not yet recruitingThis study is testing an investigational drug called golidocitinib for adults with primary immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The trial has two parts: first to find a safe dose, and then to compare the drug against a placebo to s…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Scientists test 'Universal' cell therapy for stubborn blood disorder
Disease control Not yet recruitingThis early-phase study is testing a new type of cell therapy called QT-019C in adults with a hard-to-treat form of immune thrombocytopenia (ITP), a disorder where the immune system attacks platelets. The main goal is to check if the treatment is safe and to look for early signs t…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Major study to map out how doctors treat low platelet disorder
Knowledge-focused Not yet recruitingThis study aims to understand how immune thrombocytopenia (ITP), a condition causing low platelet counts, is currently treated in China. Researchers will look back at the medical records of 500 patients to see what treatments doctors chose and how well those treatments worked. Th…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC